Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 4858 [2019-02694]

Download as PDF 4858 Federal Register / Vol. 84, No. 33 / Tuesday, February 19, 2019 / Notices scheduling priorities of the key participants. Patricia Rausch, Advisory Committee Management Officer, National Aeronautics and Space Administration. [FR Doc. 2019–02668 Filed 2–15–19; 8:45 am] BILLING CODE 4510–13–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice U.S. Nuclear Regulatory Commission. ACTION: Notice of meeting. The U.S. Nuclear Regulatory Commission will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on April 3– 4, 2019. A sample of agenda items to be discussed during the public session includes: A discussion on medicalrelated events; a discussion on the ACMUI’s recommendations and comments on revision 10 of the draft Yttrium-90 Microsphere Brachytherapy Sources and Devices TheraSphere® and SIR_Spheres® Licensing Guidance; a discussion on the summary of changes to the NRC’s requirements regarding medical use of byproduct material; a discussion of the ACMUI’s recommendations related to the appropriateness of the required reporting and notification of a medical event; a presentation from Lucerno Dynamics on the detection of nuclear medicine injection infiltrations; and a discussion on the ACMUI’s recommendations and comments on the draft Germanium-68/Gallium-68 Pharmacy Grade Generator Licensing Guidance. The agenda is subject to change. The current agenda and any updates will be available at https:// www.nrc.gov/reading-rm/doccollections/acmui/meetings/2019.html or by emailing Ms. Kellee Jamerson at the contact information below. FOR FURTHER INFORMATION CONTACT: Ms. Kellee Jamerson, email: Kellee.Jamerson@nrc.gov, telephone: (301) 415–7408. SUPPLEMENTARY INFORMATION: Purpose: Discuss issues related to 10 CFR part 35 Medical Use of Byproduct Material. Date and Time for Open Sessions: April 3, 2019, from 8:30 a.m. to 2:45 p.m. and April 4, 2019, from 8:30 a.m. to 2:45 p.m. Eastern Standard Time. Date and Time for Closed Session: April 3, 2019, from 2:45 p.m. to 5:00 p.m. Eastern Standard Time. tkelley on DSKBCP9HB2PROD with NOTICES VerDate Sep<11>2014 17:46 Feb 15, 2019 Jkt 247001 NUCLEAR REGULATORY COMMISSION Public Participation AGENCY: Any member of the public who wishes to participate in the meeting in person or via phone should contact Ms. Jamerson using the information below. The meeting will also be webcast live at https://video.nrc.gov/. SUMMARY: Conduct of the Meeting AGENCY: SUMMARY: Address for Public Meeting: U.S. Nuclear Regulatory Commission, Three White Flint North Building, Rooms 3WFN–1C03/1–C05, 11601 Landsdown Street, North Bethesda, Maryland 20852. Christopher J. Palestro, M.D., will chair the meeting. Dr. Palestro will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Jamerson using the contact information listed above. All submittals must be received by March 29, 2019, three business days before the meeting, and must pertain to the topics on the agenda for the meeting. 2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the Chairman. 3. The draft transcript and meeting summary will be available on ACMUI’s website https://www.nrc.gov/reading-rm/ doc-collections/acmui/meetings/ 2019.html on or about May 16, 2019. 4. Persons who require special services, such as those for the hearing impaired, should notify Ms. Jamerson of their planned attendance. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in title 10 of the Code of Federal Regulations, Part 7. Dated at Rockville, Maryland, on February 13, 2019. For the U.S. Nuclear Regulatory Commission. Russell E. Chazell, Federal Advisory Committee Management Officer. [FR Doc. 2019–02694 Filed 2–15–19; 8:45 am] BILLING CODE 7590–01–P PO 00000 Frm 00096 Fmt 4703 Sfmt 4703 [IA–18–043; NRC–2019–0039] In the Matter of Mr. Randy Bethea Nuclear Regulatory Commission. ACTION: Order; issuance. The U.S. Nuclear Regulatory Commission (NRC) is issuing an order prohibiting involvement in NRClicensed activities to Mr. Randy Bethea. Mr. Bethea was employed as a radiographer at Mistras Group, Inc., (Mistras). Mr. Bethea engaged in deliberate misconduct in violation of the regulations that caused Mistras to be in violation of the regulations and license condition 9.A of its license. DATES: The Order prohibiting involvement in NRC-licensed activities was issued on February 13, 2019. ADDRESSES: Please refer to Docket ID NRC–2019–0039 when contacting the NRC about the availability of information regarding this document. You may obtain publicly-available information related to this document using any of the following methods: • Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC–2019–0039. Address questions about dockets in Regulations.gov to Krupskaya Castellon; telephone: 301–287–9221; email: Krupskaya.Castellon@nrc.gov. For technical questions, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this document. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publicly available documents online in the ADAMS Public Document collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301– 415–4737, or by email to pdr.resource@ nrc.gov. The ADAMS accession number for each document referenced (if it is available in ADAMS) is provided the first time that it is mentioned in this document. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. FOR FURTHER INFORMATION CONTACT: Leelavathi Sreenivas, Office of Enforcement, U.S. Nuclear Regulatory Commission, Washington, DC 20555– E:\FR\FM\19FEN1.SGM 19FEN1

Agencies

[Federal Register Volume 84, Number 33 (Tuesday, February 19, 2019)]
[Notices]
[Page 4858]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02694]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission will convene a meeting 
of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on 
April 3-4, 2019. A sample of agenda items to be discussed during the 
public session includes: A discussion on medical-related events; a 
discussion on the ACMUI's recommendations and comments on revision 10 
of the draft Yttrium-90 Microsphere Brachytherapy Sources and Devices 
TheraSphere[supreg] and SIR_Spheres[supreg] Licensing Guidance; a 
discussion on the summary of changes to the NRC's requirements 
regarding medical use of byproduct material; a discussion of the 
ACMUI's recommendations related to the appropriateness of the required 
reporting and notification of a medical event; a presentation from 
Lucerno Dynamics on the detection of nuclear medicine injection 
infiltrations; and a discussion on the ACMUI's recommendations and 
comments on the draft Germanium-68/Gallium-68 Pharmacy Grade Generator 
Licensing Guidance. The agenda is subject to change. The current agenda 
and any updates will be available at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2019.html or by emailing Ms. Kellee Jamerson 
at the contact information below.

FOR FURTHER INFORMATION CONTACT: Ms. Kellee Jamerson, email: 
Kellee.Jamerson@nrc.gov, telephone: (301) 415-7408.

SUPPLEMENTARY INFORMATION:
    Purpose: Discuss issues related to 10 CFR part 35 Medical Use of 
Byproduct Material.
    Date and Time for Open Sessions: April 3, 2019, from 8:30 a.m. to 
2:45 p.m. and April 4, 2019, from 8:30 a.m. to 2:45 p.m. Eastern 
Standard Time.
    Date and Time for Closed Session: April 3, 2019, from 2:45 p.m. to 
5:00 p.m. Eastern Standard Time.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, 
Three White Flint North Building, Rooms 3WFN-1C03/1-C05, 11601 
Landsdown Street, North Bethesda, Maryland 20852.

Public Participation

    Any member of the public who wishes to participate in the meeting 
in person or via phone should contact Ms. Jamerson using the 
information below. The meeting will also be webcast live at https://video.nrc.gov/.

Conduct of the Meeting

    Christopher J. Palestro, M.D., will chair the meeting. Dr. Palestro 
will conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to
    Ms. Jamerson using the contact information listed above. All 
submittals must be received by March 29, 2019, three business days 
before the meeting, and must pertain to the topics on the agenda for 
the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2019.html on or about May 16, 2019.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Jamerson of their planned 
attendance.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in title 
10 of the Code of Federal Regulations, Part 7.

    Dated at Rockville, Maryland, on February 13, 2019.

    For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2019-02694 Filed 2-15-19; 8:45 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.